← Leaderboards
Rohit Kohli
Cincinnati Childrens Hosp Med Ctr
$5,277,307
Attributed
$6,753,762
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,753,762 · 5
By mechanism
R01$2,349,108 · 1
R44$2,013,280 · 1
T32$939,631 · 1
U01$849,944 · 1
K08$601,799 · 1
Top collaborators
- Norah A. Terrault3 shared
- Fabio Cohen Tucci2 shared
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoSerumLiverObesityRattusReportingOperative Surgical ProceduresMediatingLipidsMetabolicFatty LiverGastric BypassAdultLinkMalabsorption SyndromesAdolescentMorbid ObesityBariatric SurgeryComorbidityIntestinesIleumBile AcidsAcidsHepatic
Grant awards (17)
Translational Research Training in Hepatology$411,362
T32 · FY2025 · DK
Candidate selection of a LPAR1 antagonist for therapeutic application in NASH$1,041,548
R44 · FY2024 · DK
Translational Research Training in Hepatology$266,515
T32 · FY2024 · DK
Candidate selection of a LPAR1 antagonist for therapeutic application in NASH$971,732
R44 · FY2023 · DK
Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChilLDRen) Clinical Centers.$425,000
U01 · FY2023 · DK · contact PI
Translational Research Training in Hepatology$261,754
T32 · FY2023 · DK
Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChilLDRen) Clinical Centers.$424,944
U01 · FY2022 · DK · contact PI
NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling$482,124
R01 · FY2019 · DK · contact PI
NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling$482,124
R01 · FY2018 · DK · contact PI
NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling$482,124
R01 · FY2017 · DK · contact PI
NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling$451,720
R01 · FY2016 · DK · contact PI
NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling$451,016
R01 · FY2015 · DK · contact PI
Role of Ileum in Reducing Obesity Related Comorbidities$540
K08 · FY2013 · DK · contact PI
Role of Ileum in Reducing Obesity Related Comorbidities$149,927
K08 · FY2012 · DK · contact PI
Role of Ileum in Reducing Obesity Related Comorbidities$150,444
K08 · FY2011 · DK · contact PI
Role of Ileum in Reducing Obesity Related Comorbidities$150,444
K08 · FY2010 · DK · contact PI
Role of Ileum in Reducing Obesity Related Comorbidities$150,444
K08 · FY2009 · DK · contact PI